Related Experiment Video
Updated: Mar 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
Andrelou F Vallarelli1,2,3, P Sivaramakrishna Rachakonda4, Jocelyne André1,2
1INSERM, U976, Skin Research Centre, Hôpital Saint-Louis, Paris, F-75010, France.
Abstract:
The mechanism of telomerase re-activation in cancer had remained elusive until the discovery of frequent mutations in the promoter of the TERT gene that encodes the catalytic reverse transcriptase subunit of telomerase. We investigated the regulation of TERT expression in melanoma cell lines and our results show that promoter mutations render TERT expression dependent on MAPK activation due to oncogenic BRAF or NRAS mutations. Mutations in the TERT promoter create binding sites for ETS transcription factors. ETS1, expressed in melanoma cell lines, undergoes activating phosphorylation by ERK at Thr38 residue as a consequence of constitutively activated MAPK pathway. We demonstrate that ETS1 binds on the mutated TERT promoter leading to the re-expression of the gene. The inhibition of ETS1 resulted in reduced TERT expression. We provide evidence that the TERT promoter mutations provide a direct link between TERT expression and MAPK pathway activation due to BRAF or NRAS mutations via the transcription factor ETS1.
Insights
TERT promoter mutations in cancer reactivate telomerase by creating ETS transcription factor binding sites. This links MAPK pathway activation from BRAF/NRAS mutations to TERT expression via ETS1.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Telomere maintenance is crucial for cancer cell immortality.
- Telomerase re-activation in cancer was poorly understood.
- TERT promoter mutations were recently discovered in various cancers.
Purpose of the Study:
- To investigate the mechanism of TERT gene re-expression in melanoma.
- To elucidate the link between TERT promoter mutations and MAPK pathway activation.
Main Methods:
- Analysis of TERT expression in melanoma cell lines.
- Investigation of transcription factor binding to the mutated TERT promoter.
- Assessment of ETS1 phosphorylation and its role in TERT regulation.
- Inhibition of ETS1 to determine its effect on TERT expression.
Main Results:
- TERT promoter mutations create ETS transcription factor binding sites.
- Melanoma cell lines with oncogenic BRAF or NRAS mutations show MAPK pathway activation.
- Activated MAPK pathway leads to ETS1 phosphorylation and binding to the mutated TERT promoter.
- ETS1 binding drives TERT re-expression; ETS1 inhibition reduces TERT expression.
Conclusions:
- TERT promoter mutations directly link MAPK pathway activation to TERT gene re-expression in melanoma.
- The transcription factor ETS1 is a key mediator in this process.
- This mechanism provides insight into telomerase reactivation in cancer.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons

